Author response for 'Daratumumab for Relapsed or Refractory AL Amyloidosis with high Plasma Cell Burden'
- Resource Type
- Source
- Subject
medicine.medical_specialty medicine.anatomical_structure Refractory business.industry High plasma Internal medicine Cell medicine AL amyloidosis Daratumumab medicine.disease business Gastroenterology - Language